Latest Financial Position News

DeSoto Resources has accelerated its exploration efforts with promising gold assay results in Guinea and initial rare earth drilling in Australia’s Northern Territory, supported by a strong cash position.

Titomic has launched a major US manufacturing hub in Alabama, secured key defense contracts, and expanded leadership to accelerate its global additive manufacturing ambitions.

Epx Limited reports sustained operational improvement with four consecutive quarters of positive cash inflows and a 26% increase in customer receipts for the June 2025 quarter.

Cooper Metals Limited reports steady progress across its copper-gold exploration portfolio in Queensland and Western Australia, underpinned by a solid cash position and advancing regulatory approvals.

Waypoint REIT’s half-year update reveals a 3.4% portfolio valuation increase to $2.89 billion, alongside a strategic pause in its $50 million buyback program after $32.9 million in purchases.

Catalyst Metals reported steady gold production in the June 2025 quarter, progressing development at its Trident project while completing key corporate transactions that strengthen its growth outlook.

Merchant House International has completed the sale of its American Merchant, Inc. assets, generating significant profits and setting the stage for winding up operations and voluntary delisting from the ASX.

Future Battery Minerals Ltd has acquired 100% ownership of the Miriam Project, extinguishing royalties and advancing multiple high-priority gold targets with initial drilling completed. Assay results are expected in early September 2025.

InVert Graphite Limited has successfully raised $3.5 million and resumed ASX trading following key acquisitions and promising initial trench results at its Morogoro Graphite Project.

Karoon Energy reported a 25% jump in net revenue interest production for Q2 2025, driven by operational recovery and the Baúna FPSO acquisition. The company also advanced its Neon development with a significant resource upgrade.

Island Pharmaceuticals reported promising Phase 2a/b trial results for its dengue drug ISLA-101 and secured a strategic acquisition of the broad-spectrum antiviral Galidesivir, bolstering its pipeline and balance sheet.

Metal Powder Works has significantly expanded its production capacity and customer base in the June 2025 quarter, while securing strategic partnerships that position it strongly in defence and nuclear sectors.